论文部分内容阅读
目的评价Deep球囊血管成形联合动脉灌注治疗糖尿病足的临床价值。方法将34例糖尿病足患者随机分为两组:研究组(n=17)进行经皮腔内血管成形术(PTA)联合动脉灌注治疗;对照组(n=17)接受局部清创、抗生素及胰岛素等常规治疗。对两组追踪观察6～9个月。结果研究组总有效率为86.96%,对照组总有效率为60.87%,两组相比差异有统计学意义(P<0.05)。结论 Deep球囊血管成形联合动脉灌注治疗糖尿病足的疗效优于常规治疗,可以大大降低患者的病残率。
Objective To evaluate the clinical value of Deep balloon angioplasty combined with arterial infusion in the treatment of diabetic foot. Methods 34 patients with diabetic foot were randomly divided into two groups: the study group (n = 17) underwent percutaneous transluminal angioplasty (PTA) combined with arterial infusion; the control group (n = 17) received local debridement, antibiotics and Insulin and other conventional treatment. The two groups were followed up for 6 to 9 months. Results The total effective rate was 86.96% in the study group and 60.87% in the control group. There was significant difference between the two groups (P <0.05). Conclusion Deep balloon angioplasty combined with arterial infusion of diabetic foot treatment is superior to conventional treatment, which can greatly reduce the patient’s morbidity.